Literature DB >> 6253487

Stabilization of proteins by guanidination.

P Cupo, W El-Deiry, P L Whitney, W M Awad.   

Abstract

Earlier studies have indicated the marked resistance of two pronase endopeptidases to denaturation in high concentrations of urea or guanidine hydrochloride (Siegel, S., and Awad, W. M., Jr. (1973) J. Biol. Chem. 248, 3233--3240). One component has only a single residue of lysine and the other has none. The consideration arose that lysine-containing peptide segments may be less stable than those containing arginine because of the fluctuations of the side groups of the former residue. The small epsilon amino groups may not be able to sustain solvation of the hydrophobic arm in an aqueous medium. Arginine residues have shorter hydrophobic arms, larger hydrophilic groups, and higher pKa values and, thus may be less motile than lysine. The hypothesis was tested by guanidination of seven globular proteins (bovine carbonic anhydrase, chymotrypsinogen, alpha-lactalbumin, serum albumin, ribonuclease, hen egg lysozyme, and horse heart cytochrome c). Conversion of lysine residues to homoarginine was between 90 and 99%. Tritium-hydrogen isotope exchange revealed that all proteins except lysozyme demonstrated reduced out-exchange after guanidination. The results with lysozyme were not unexpected since only this protein has a high arginine to lysine ratio. These findings suggest that high arginine to lysine ratios contribute to protein stability.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Stability of protein pharmaceuticals.

Authors:  M C Manning; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

2.  Combinatorial Labeling Method for Improving Peptide Fragmentation in Mass Spectrometry.

Authors:  Bhanuramanand Kuchibhotla; Sankara Rao Kola; Jagannadham V Medicherla; Swamy V Cherukuvada; Vishnu M Dhople; Madhusudhana Rao Nalam
Journal:  J Am Soc Mass Spectrom       Date:  2017-03-27       Impact factor: 3.109

3.  Arginyl residues and thermal stability in proteins.

Authors:  F S Qaw; J M Brewer
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

4.  Role of the alpha-amino group of protein in ubiquitin-mediated protein breakdown.

Authors:  A Hershko; H Heller; E Eytan; G Kaklij; I A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

5.  Effects of temperature on the degradation of proteins in rabbit reticulocyte lysates and after injection into HeLa cells.

Authors:  R Hough; M Rechsteiner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein.

Authors:  Ulrich Baxa; Vladislav Speransky; Alasdair C Steven; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  Changes in solvent exposure reveal the kinetics and equilibria of adsorbed protein unfolding in hydrophobic interaction chromatography.

Authors:  R W Deitcher; J P O'Connell; E J Fernandez
Journal:  J Chromatogr A       Date:  2010-06-25       Impact factor: 4.759

Review 8.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

9.  Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production.

Authors:  S Chattong; J Tanamai; P Kiatsomchai; M Nakatsu; A Sereemaspun; N Pimpha; K Praditpornsilpa; R Rojanathanes; A Sethpakadee; K Tungsanga; S Eiam-Ong; K Manotham
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 10.  Hydrogen exchange and the dynamic structure of proteins.

Authors:  C Woodward; I Simon; E Tüchsen
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.